NDC 0078-0813 Tobrex
Tobramycin Ointment Ophthalmic
Product Information
What is NDC 0078-0813?
The NDC code 0078-0813 is assigned by the FDA to the product Tobrex which is a human prescription drug product labeled by Novartis Pharmaceuticals Corporation. The generic name of Tobrex is tobramycin. The product's dosage form is ointment and is administered via ophthalmic form. The product is distributed in a single package with assigned NDC code 0078-0813-01 3.5 g in 1 tube . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.
What are the uses for Tobrex?
This medication is used to treat eye infections. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.
Product Packages
Product Details
What are Tobrex Active Ingredients?
- TOBRAMYCIN 3 mg/g - An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
Tobrex Active Ingredients UNII Codes
- TOBRAMYCIN (UNII: VZ8RRZ51VK)
- TOBRAMYCIN (UNII: VZ8RRZ51VK) (Active Moiety)
NDC to RxNorm Crosswalk
- RxCUI: 207850 - Tobrex 0.3 % Ophthalmic Ointment
- RxCUI: 207850 - tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobrex]
- RxCUI: 207850 - Tobrex 0.003 MG/MG Ophthalmic Ointment
- RxCUI: 313414 - tobramycin 0.3 % Ophthalmic Ointment
- RxCUI: 313414 - tobramycin 0.003 MG/MG Ophthalmic Ointment
Tobrex Inactive Ingredients UNII Codes
- CHLOROBUTANOL (UNII: HM4YQM8WRC)
- MINERAL OIL (UNII: T5L8T28FGP)
- PETROLATUM (UNII: 4T6H12BN9U)
Pharmacologic Class(es)
* Please review the disclaimer below.
Tobrex Product Label
FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Product Label Table of Contents
Description
TOBREX® (tobramycin ophthalmic ointment) 0.3% is a sterile topical ophthalmic antibiotic formulation prepared specifically for topical therapy of external ophthalmic infections.
Each gram of TOBREX (tobramycin ophthalmic ointment) 0.3% contains: Active: tobramycin 0.3% (3 mg). Preservative: chlorobutanol 0.5%. Inactives: mineral oil, white petrolatum.
Tobramycin is a water-soluble aminoglycoside antibiotic active against a wide variety of gram-negative and gram-positive ophthalmic pathogens.
The chemical structure of tobramycin is:
Molecular Formula:
C18H37N5O9
Molecular Weight: 467.52 g/mol
Chemical Name:
0-{3-amino-3-deoxy-α-D-gluco-pyranosyl-(1→4) }-0-{2,6-diamino-2,3,6-trideoxy-α-D-ribohexo-pyranosyl-(1→6) }-2-deoxystreptamine.
Clinical Pharmacology
In Vitro Data: In vitro studies have demonstrated tobramycin is active against susceptible strains of the following microorganisms: Staphylococci, including S. aureus and S. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant strains.
Streptococci, including some of the Group A-beta-hemolytic species, some nonhemolytic species, and some Streptococcus pneumoniae.
Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae and H. aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus and some Neisseria species. Bacterial susceptibility studies demonstrate that in some cases, microorganisms resistant to gentamicin retain susceptibility to tobramycin.
Indications And Usage
TOBREX® (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. Appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of TOBREX (tobramycin ophthalmic ointment) 0.3%. Clinical studies have shown tobramycin to be safe and effective for use in children.
Contraindications
TOBREX (tobramycin ophthalmic ointment) 0.3 % is contraindicated in patients with known hypersensitivity to any of its components.
Warnings
NOT FOR INJECTION INTO THE EYE. Sensitivity to topically applied aminoglycosides may occur in some patients. Severity of hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching, urticaria, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If a sensitivity reaction to TOBREX (tobramycin ophthalmic ointment) 0.3% occurs, discontinue use.
Precautions
General: As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated. Ophthalmic ointments may retard corneal wound healing.
Cross-sensitivity to other aminoglycoside antibiotics may occur; if hypersensitivity develops with this product, discontinue use and institute appropriate therapy.
Patients should be advised not to wear contact lenses if they have signs and symptoms of ocular infections.
Dosage And Administration
In mild to moderate disease, apply a half-inch ribbon into the affected eye(s) 2 or 3 times per day. In severe infections, instill a half-inch ribbon into the affected eye(s) every 3 to 4 hours until improvement, following which treatment should be reduced prior to discontinuation.
How to Apply TOBREX (tobramycin ophthalmic ointment) 0.3%:
1. Tilt your head back.
2. Place a finger on your cheek just under your eye and gently pull down until a ''V'' pocket is formed between your eyeball and your lower lid.
3. Place a small amount (about ½ inch) of TOBREX® (tobramycin ophthalmic ointment) 0.3% in the ''V'' pocket. Do not let the tip of the tube touch your eye.
4. Look downward before closing your eye.
How Supplied
TOBREX (tobramycin ophthalmic ointment) 0.3% is supplied as a 3.5 g sterile ointment in an aluminum tube with a white polyethylene tip and white polyethylene cap as follows:
3.5 g containing tobramycin 0.3% (3 mg/g).................................................. NDC 0078-0813-01
Storage: Store at 2°C to 25°C (36°F to 77°F).
After opening, TOBREX (tobramycin ophthalmic ointment) 0.3% can be used until the expiration date on the tube.
Distributed by:
Novartis Pharmaceuticals Corporation
East Hanover, New Jersey 07936
© Novartis
Revised: June 2021
T2021-76
Principal Display Panel
NDC 0078-0813-01
Tobrex®
(tobramycin ophthalmic
ointment) 0.3%
Sterile 3.5 g Net Wt.
NOVARTIS
* Please review the disclaimer below.